Key Findings/Learnings from the 2020 Meeting Related to Anticoagulation

 

Drs. Jeffrey Weitz and Saskia Middledorp discuss the information discussed at the 2020 ISTH Virtual Congress. Topics include new information about the use of aspirin, unusual site thrombosis, and major trials released during the meeting.

Previous Article COVID-19, Anticoagulation, and the 2020 Virtual ISTH Meeting
Next Article Discussing the Impact COVID-19 Has Had on Hemophilia Management and the Major Findings from the 2020 Virtual Meeting
Print